SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 14.84 |
| Enterprise Value ($M) | -43.06 |
| Book Value ($M) | 51.64 |
| Book Value / Share | 1.25 |
| Price / Book | 0.29 |
| NCAV ($M) | 50.11 |
| NCAV / Share | 1.21 |
| Price / NCAV | 0.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.72 |
| Return on Assets (ROA) | -0.38 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.36 |
| Current Ratio | 5.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 63.57 |
| Assets | 65.10 |
| Liabilities | 13.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rosalind Advisors, Inc. | 0.00 | ||
| 13D/A | RiverVest Venture Fund III, L.P. | 4.20 | -50.12 | |
| 13G/A | 5AM Opportunities II, L.P. | 4.10 | -57.14 | |
| 13G/A | Armistice Capital, Llc | 4.99 | -2.72 | |
| 13G/A | Radoff Bradley Louis | 9.60 | 40.71 | |
| 13D/A | Novo Holdings A/S | 3.90 | -39.91 | |
| 13D/A | HealthCap VIII, L.P. | 8.90 | 0.00 | |
| 13G/A | Rock Springs Capital Management LP | 6.41 | 60.79 | |
| 13G/A | Citadel Advisors Llc | 0.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,633 | 70,656 | 12.22 | |
| 51,597 | 86,041 | 59.97 | |
| 28,740 | 129,748 | 22.15 | |
| 157,972 | 383,177 | 41.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SNTI – Senti Biosciences, Inc. | SNYR – Synergy CHC Corp. |
| SONN – Sonnet BioTherapeutics Holdings, Inc. | SRZN – Surrozen, Inc. |
| SXTC – China SXT Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io